Posted in | News | Display | Imaging

Zecotek Photonics Granted Patent for 3D Auto-Stereoscopic Display System

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the European Patent Office has issued a Notice of Allowance, and the Eurasian Patent Office has issued a Notification on Readiness to Grant a Eurasian Patent, for the 3D/2D switchable optical imaging system for its glasses-free 3D auto-stereoscopic display system.

The European Notice of Allowance and the Eurasian Notification on Readiness add to the other global patents, including U.S. patent number 7,944,465 covering glasses-free 3D auto-stereoscopic display system, strengthening Zecotek’s worldwide patent position as the Company moves to fully commercialize its innovative 3D technology and other photonics technology.

"We take considerable care in the protection of our intellectual property and receiving the Notice of Allowance from the European Union for our glasses-free 3D display system is very important to the overall commercialization of this valuable technology," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc.  "Our 3D auto-stereoscopic display offers a real volumetric 3D viewing experience with one of the widest viewing angles and the highest resolution compared to competing technologies, and it is critical that the IP be protected.  Our objective is to pursue full commercialization of our 3D technology with a strategic partner."

The European patent allowance includes all countries of the European Union.  The Eurasia Patent Organization includes 9 former-Soviet nations: Russian Federation, Republic of Kazakhstan, Turkmenistan, Kyrgyz Republic, Republic of Belarus, Republic of Tajikistan, Republic of Azerbaijan, Republic of Moldova and Republic of Armenia.  The European and Eurasian patent allowances cover the 3D/2D switchable optical imaging system of Zecotek’s Real-Time 3D Display. The 3D/2D switchable optical imaging system further improves the core capabilities of the 3D display technology by introducing a software-selectable full-resolution 2D mode with viewing angles and dynamic range/colour depth on par with conventional 2D displays. The patent covers technology for both 3D and 2D modes, dynamic adjustment of viewing angle, number and width of viewing zones as well as the functionality to dynamically control the positioning of different viewing zones.

Zecotek’s patented Real-Time 3D Display System is based on the auto-stereoscopic principle, but with substantial innovative.  It has the capability of simultaneously presenting to multiple users both 3D and 2D images on the same screen with separate views and at different viewing angles.  The 3D display system provides comfortable conditions for viewing a volumetric representation without eye strain.  The viewing of such 3D images does not require the use of any supplementary means such as glasses, does not drastically limit the position of the viewer with respect to the display, and allows simultaneous viewing of the 3D display by many viewers from a sufficiently wide field of view.

Patents have now been granted to Zecotek for its 3D display system in Europe, Eurasia, the United States and Australia. Patents have been filed and are pending in Japan, China, Korea, and India.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zecotek Photonics. (2019, February 28). Zecotek Photonics Granted Patent for 3D Auto-Stereoscopic Display System. AZoOptics. Retrieved on March 01, 2024 from

  • MLA

    Zecotek Photonics. "Zecotek Photonics Granted Patent for 3D Auto-Stereoscopic Display System". AZoOptics. 01 March 2024. <>.

  • Chicago

    Zecotek Photonics. "Zecotek Photonics Granted Patent for 3D Auto-Stereoscopic Display System". AZoOptics. (accessed March 01, 2024).

  • Harvard

    Zecotek Photonics. 2019. Zecotek Photonics Granted Patent for 3D Auto-Stereoscopic Display System. AZoOptics, viewed 01 March 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.